Drawing for MEDIHERE

USPTO serial 90855668

MEDIHERE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MONINGHOFF, KIM TERESA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDIHERE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tammy J. Terry

Tammy J. Terry Osha Bergman Watanabe & Burton LLP1100 Louisiana StreetSuite 4900Houston, TX 77002

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for use in telemedicine, namely, for scheduling appointments, and facilitating video conferences between patients and doctors and other medical professionals; Downloadable computer software for use in remote prescription, namely, for requesting prescriptions, and transmitting the prescriptions to pharmacies; Downloadable mobile application for use in telemedicine, namely, for scheduling appointments, and facilitating video conferences between patients and doctors and other medical professionals ; Downloadable mobile application for use in remote prescription, namely, for requesting prescriptions, and transmitting the prescriptions to pharmacies; Recorded computer software for use in telemedicine, namely, for scheduling appointments, and facilitating video conferences between patients and doctors and other medical professionals; Recorded computer software for use in remote prescription, namely, for requesting prescriptions, and transmitting the prescriptions to pharmacies; Recorded mobile application for use in telemedicine, namely, for scheduling appointments, and facilitating video conferences between patients and doctors and other medical professionals; Recorded mobile application for use in remote prescription, namely, for requesting prescriptions, and transmitting the prescriptions to pharmacies; Downloadable computer software for accessing, reading, and tracking information in the field of patient medical records; Recorded computer software for accessing, reading, and tracking information in the field of patient medical records; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the patient's body, namely, the heart; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating physical condition of patient, namely, heart arrhythmia; downloadable and recorded Mobile operating system software; downloadable and recorded Computer operating system software; downloadable and recorded Computer programs for connecting remotely to computers or computer networks; downloadable and recorded Computer programs for the enabling and controlling of access to computers and facilitiesACTIVE—
038Providing access to the Internet; Providing on-line chat room; Transmission service of message via the computer network; Transmission service of audio and video material via the computer network; Providing video conference service via the computer network; Providing access to global computer network; Providing access to database; Streaming service of audio and video material on the Internet; Transmission service of digital file via the computer network; Providing call service, namely, voice communication services, using radio, telephone and other electronic communication means; Information providing service via the computer network, internet or wireless communication, namely, providing information in the field of telecommunications; Providing electronic bulletin board service; Interstate telephone service; International telephone service; Mobile telephone communication; Providing telephone conferencing services; Communication by electronic computer terminals; Providing virtual private network (VPN) servicesACTIVE—
044Medical clinics; Telemedicine services; Nursing services; Hospital services; Home-visit Nursing care; Healthcare services; Mobile healthcare services; Providing medical information; Medical diagnostic testing, monitoring and reporting services; Physical examination services; Medical assistance services; Medical consultationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 3, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 3, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 29, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2022NEWNNEW NOA TO ISSUE—
Jul 28, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 26, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
May 31, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 11, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Apr 28, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 28, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 28, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 26, 2022DOCKASSIGNED TO EXAMINER—
Sep 27, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance